Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India · Delayed Price · Currency is INR 168.90
-4.19 (-2.42%)
May 11, 2026, 3:30 PM IST
NSE:SPARC Revenue
Sun Pharma Advanced Research Company had revenue of 84.50M INR in the quarter ending December 31, 2025, a decrease of -43.33%. This brings the company's revenue in the last twelve months to 531.36M, down -13.08% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharma Advanced Research Company had annual revenue of 717.66M, down -5.00%.
Revenue (ttm)
531.36M
Revenue Growth
-13.08%
P/S Ratio
102.88
Revenue / Employee
1.68M
Employees
316
Market Cap
54.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 717.66M | -37.79M | -5.00% |
| Mar 31, 2024 | 755.45M | -1.63B | -68.36% |
| Mar 31, 2023 | 2.39B | 1.02B | 73.98% |
| Mar 31, 2022 | 1.37B | -1.16B | -45.74% |
| Mar 31, 2021 | 2.53B | 1.76B | 229.31% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alembic Pharmaceuticals | 72.67B |
| Strides Pharma Science | 47.26B |
| Akums Drugs and Pharmaceuticals | 42.60B |
| Alivus Life Sciences | 25.12B |
| Indoco Remedies | 18.49B |
| Aarti Pharmalabs | 18.01B |
| Innova Captab | 16.37B |
| Solara Active Pharma Sciences | 12.55B |
Sun Pharma Advanced Research Company News
- 11 days ago - Sun Pharma Advanced Research Company sells priority review voucher for $195 million - Business Upturn
- 5 weeks ago - Why Sun Pharma shares are falling nearly 3% today? Epxlained - Business Upturn
- 3 months ago - Sun Pharma receives FDA Rare Pediatric Disease Priority Review Voucher for Sezaby - Business Upturn
- 4 months ago - Sun Pharma Advanced Research Company Transcript: R&D Day 2026 - Transcripts
- 5 months ago - Sparc shares surge 27% in 2 days – Know the reason behind the rally - Business Upturn
- 5 months ago - Why are SPARC shares up 20% today; Explained - Business Upturn
- 6 months ago - SPARC to announce Q2 results on November 10 - Business Upturn
- 10 months ago - Sun Pharma Advanced Research Q1 Results: Net loss narrows to Rs 51.8 crore, Revenue drops 42.6% YoY - Business Upturn